CBSC announces $375,000 Noventis Medical purchase order and new recurring revenue program for MyCardia AT cardiac monitoring devices.

Sep 11

Cardiac Biotech

Cardiac Biotech

CBSC Announces $375,000 Purchase Order and Launch of Recurring Revenue Program with Noventis Medical

CBSC secures $375K purchase order with Noventis Medical and launches recurring revenue program for MyCardia AT devices.
Cardiac Biotech Solutions signs exclusive $600K Noventis Medical distribution agreement for Latin America.

Sep 04

Cardiac Biotech

Cardiac Biotech

Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina

Cardiac Biotech Solutions, Inc. signs $600K exclusive distribution deal with Noventis Medical, expanding cardiac monitoring reach into Latin America.

Sep 06

Cardiac Biotech

Cardiac Biotech

CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor

Updated product to include significant operating improvements and material design advances over the current offering

May 24

Cardiac Biotech

Cardiac Biotech

Enters Regulatory Testing Phase for Updated myCam Cardiac Event Monitoring Device

Enhanced product to include significant operating enhancements and material design advances over the current offering

How can we help you?

Contact Us

© 2020-2026. Cardiac Biotech Solutions, Inc. - All rights reserved. | Designer

Get our news in your inbox!

Join our newsletter and we will send our news directly to you.